When I speak with accountants about tokenised assets, the first question is almost always the same: "Which accounting ...
Wi-Fi standards remain as confusing as ever.
Ionis wins FDA approval to expand Tryngolza to severe hypertriglyceridemia, opening a broader market as the first approved ...
When life sciences startups think about patent strategy, the natural instinct is to focus on the core science — the novel compound, the ...
FDA-positive path for sonelokimab in HS, strong VELA data and BLA timing through 2026, plus more. Click for this MLTX update.
The article explains the most common DPT-3 classification errors that can expose companies and directors to penalties under the Companies Act. It also highlights the extended filing deadline and ...
Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. New York Gov. Kathy Hochul speaks at a news ...
Taysha Gene Therapies (TSHA) remains a Buy on strong TSHA-102 Rett data, FDA-aligned pivotal path, and cash to 2028—read the ...
Voice phishing victims will soon be able to submit documents through a mobile app without visiting a bank branch in person.
Patent disputes often appear technical, but recent judgments from the Delhi and Madras High Courts show why they matter ...
Reform UK will be forced to change their campaign strategy in the wake of their performance in the Makerfield by-election if they want to win power in 2029, party insiders and pollsters have said.
Detailed price information for Fractyl Health Inc (GUTS-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results